Breaks Categories: Stock Spotlights

FridaySep 24, 2021 1:56 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continuing Momentum to Grow Sales, Revenue

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is a pioneer in cannabis and hemp-derived product lines, strategically positioning itself to be among the top three multistate operators of these products within the American market. In late July of this year, the company released its Q1 2021 financial results in what Brand Rogers, RWB Chairman and CEO, described as “another great quarter for the company.” A recent article reads, “When making the announcement, Mr. Rogers also noted that the company would be building on the momentum from Q1, given how much traction it had received for its brand. More…

Continue Reading

FridaySep 17, 2021 3:11 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Leveraging IoT Devices, AI Analytics to Provide Innovative Plant-Based Treatments

RYAH Group (CSE: RYAH), a connected device and big data and technology company, recently released a report outlining cannabis treatment options to address symptoms and conditions associated with HIV and AIDS. The report is based on information compiled by the RYAH Data Ecosystem, which enabled patients to submit data outlining symptoms they addressed with the use of cannabis, in addition to detailing specific cannabis strains used to treat those conditions. A recent article reads, “The ground-breaking report is part of RYAH’s data-driven mission to provide innovative plant-based medical treatments that leverage the use of IoT (Internet of Things) dose-measuring devices…

Continue Reading

FridaySep 17, 2021 2:58 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enables Rapid, Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of proprietary patented drug-delivery platform DehydraTECH(TM), recently released partial results from human clinical study HYPER-H21-1. The study evaluated DehydraTECH-processed cannabidiol (“CBD”) for potential application against hypertension/high blood pressure. “The partial results showed that blood pressure was reduced across both male and female volunteers; it was more pronounced with DehydraTECH-CBD in the study’s first 10 to 50 minutes. These results reinforced the pre-existing findings demonstrating that DehydraTECH delivers superior performance over generic CBD controls,” reads a recent article. Lexaria was also pleased that the subjects of this human clinical study tolerated the DehydraTECH-CBD,…

Continue Reading

TuesdaySep 14, 2021 3:06 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding Retail, Cultivation Footprint in Florida

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a company leveraging brand acquisitions and partnerships to become one of the top three multistate operators in the U.S. legal cannabis and hemp market, recently completed the acquisition of an operational 45,000-square-foot greenhouse sited on 4.7 acres of land in Apopka, Florida. According to the GM of RWB Florida, Jim Frazier, who is quoted in a recent article, “The Apopka acquisition cements the fact that we are committed to expansion in Florida, which is in line with the overall company’s growth strategy across the country.” The acquisition follows that of the…

Continue Reading

FridaySep 03, 2021 1:55 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Proprietary Technology Elevating Quantity of Drugs Delivered Across Blood-Brain Barrier by 1,900%

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced that a tolerability and pharmacokinetic study, performed by an independent, premier animal testing laboratory in the U.S., had demonstrated that administration of colchicine using its proprietary DehydraTECH(TM) resulted in increased delivery. “Colchicine is an approved therapeutic with anti-inflammatory effects primarily used to treat gout and cardiac conditions such as pericarditis. It was the latest of several drugs Lexaria tested with known SARS-CoV-2/COVID-19 antiviral properties after it showed potent effects in mitigating the cytokine storm associated with the virus. Additionally, colchicine is occasionally used to treat emergent pericarditis in children, which would make the…

Continue Reading

FridaySep 03, 2021 1:41 pm

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Subsidiary Supplying Bottled Water to BC Firefighters Sourced from the Very Land They Protect

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced that its wholly owned subsidiary Naturo Group had been selected to manufacture and supply a special, limited-edition run of its TRACE-branded, alkaline spring water to the BC Wildfire Services, which employs 1,100 Type 1 firefighters. BevCanna president Melise Panetta is quoted in a recent article as saying, “We are proud to be providing the firefighters with a special edition of our TRACE-branded natural 7.7pH alkaline spring water, sourced directly from our proprietary BC interior aquifer – the very land and…

Continue Reading

FridayAug 27, 2021 1:07 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Is ‘Outrageously Fast’ in Oral to Bloodstream Delivery

Lexaria Bioscience Corp. (NASDAQ: LEXX) on July 22 announced it had met three primary objectives in its investigation of antiviral drug conversion process outcomes as the drugs are processed with its patented DehydraTECH(TM). “The success achieved during the company’s testing paves the way for larger analysis of the DehydraTECH-processed drugs in vivo in animals infected with SARS-CoV-2/COVID-19, HIV/AIDS, or other infectious disease-causing viruses, according to the company. The ultimate aim is to form partnerships with established pharmaceutical industry drug-makers who may be interested in incorporating DehydraTECH technology with those tested drugs, or other drugs with similar characteristics,” reads a recent…

Continue Reading

TuesdayAug 24, 2021 1:24 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Identifying Significant Trends in Plant Therapy

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is working with researchers to provide a full turnkey solution for clinical studies from start to finish. “As research restrictions throughout the U.S. lift, RYAH Group is standing by, ready to provide IoT hardware, software and data analytics that reduce variations in patient-related clinical trials. One of the areas that the U.S. is poised to explore is cannabis in sports medicine,” reads a recent article. Sports organizations must rethink their strict policies with the legalization of recreational and medicinal cannabis across the country. The good news is…

Continue Reading

TuesdayAug 24, 2021 1:08 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Eyes White-Label Opportunity in Expanding Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, is looking to leverage its position in the growing market as a white-label manufacturer of infused-cannabis beverage brands. A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR from 2019 to 2025 has companies such as BevCanna anticipating increased numbers as well. A recent article, which contains excerpts from the report by Million Insights, notes, “‘The increasing demand for the health and wellness drink is boosting the market growth,’ the report states… Another insight offered by the report…

Continue Reading

TuesdayAug 24, 2021 10:59 am

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Continues Strong Growth Streak

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) reported another record year when it announced fiscal 2021 results. “The company’s FY 2021 numbers show record revenue of $46 million, a 20% year-over-year increase for the country’s largest independent alkaline water company,” reads a recent article. WTER president and CEO Richard A. Wright noted that the results marked a continuation of “our streak of never having a down or flat year,” further stating that the company’s employees and business partners rose to the occasion throughout last year. The company has seen significant sales into fiscal 2022. In addition to financial highlights,…

Continue Reading